Partnerships for the Development of Host-Targeted Therapeutics to Limit Antimicrobial Resistance (R01)

Archived

National Institutes of Health

Description

The purpose of this Funding Opportunity Announcement (FOA) is to solicit research applications for milestone-driven projects focused on preclinical development of candidate therapeutics that target host-encoded functions required for infection, replication, virulence, proliferation and/or pathogenesis of select bacterial pathogens for which drug resistance poses a significant public health concern.

Who can apply

  • State governments
  • County governments
  • City or township governments
  • Special district governments
  • Independent school districts
  • Public and State controlled institutions of higher education
  • Native American tribal governments (Federally recognized)
  • Public housing authorities / Indian housing authorities
  • Native American tribal organizations (other than Federally recognized)
  • Nonprofits with 501(c)(3) status (other than higher education)
  • Nonprofits without 501(c)(3) status (other than higher education)
  • Private institutions of higher education
  • For-profit organizations other than small businesses
  • Small businesses
  • Others

Contact

NIH OER Webmaster<br/>FBOWebmaster@OD.NIH.GOV<br/>
FBOWebmaster@OD.NIH.GOV

Key dates & funding
  • PostedJun 5, 2015
  • ClosesSep 17, 2015
  • Program funding$11,500,000
  • CFDA93.855, 93.856
Categories

Pro insight

Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.

Unlock with Pro